PLAY PODCASTS
Pure Global: Malaysia's MedTech Crackdown - New Hidden Compliance Traps

Pure Global: Malaysia's MedTech Crackdown - New Hidden Compliance Traps

ASEAN MedTech Insights · Ran Chen

January 3, 20262m 1s

Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In the fast-evolving ASEAN MedTech landscape, Malaysia just raised the compliance stakes. In the last week of 2025, the Medical Device Authority (MDA) released stringent new guidelines for device advertising and post-market surveillance. This episode of ASEAN MedTech Insights breaks down exactly what these changes mean for manufacturers and why your current marketing and quality assurance strategies might now be non-compliant. We dive deep into the expanded definition of "advertising," which now covers B2B communications and social media, and unpack the new proactive post-market reporting requirements that mirror the tough European MDR standards. This is a critical update for any MedTech company operating in or entering the Malaysian market. **A Critical Scenario:** Imagine your company uses LinkedIn and key opinion leaders to market its innovative diagnostic software to hospitals across Malaysia. As of last week, this entire strategy could be deemed illegal advertising by the MDA, putting your market access at immediate risk. Are you prepared to navigate this new regulatory minefield? **In this episode, you will learn:** - Why your B2B LinkedIn posts could now violate Malaysian law? - What are the new mandatory safety reports you must now submit? - How is Malaysia's regulatory framework starting to mirror the EU MDR? - Is your local representative truly prepared for these stricter vigilance demands? - What are the first three steps you must take to audit your marketing materials? - How can you turn this new regulatory burden into a competitive advantage? - What are the hidden costs associated with these updated guidelines? - Which types of devices are under the highest level of scrutiny? Navigating these regulatory shifts requires more than a checklist; it demands local expertise and a proactive strategy. Pure Global offers end-to-end regulatory consulting for MedTech companies, using advanced AI and on-the-ground experts to streamline market access in Malaysia and over 30 other countries. Don't let regulatory surprises derail your ASEAN growth. Contact us at [email protected] or visit https://pureglobal.com/ to secure your market presence.